Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
Syndax Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type |
Security Class Title |
Fee Calculation or
Carry Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration Fee |
Carry Forward Form Type |
Carry Forward File Number |
Carry Forward Initial Effective Date |
Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
| Newly Registered Securities | ||||||||||||||||||||||||
| Feeds to be Paid |
Equity | Common stock, $0.0001 par value per share | Rule 457(r) | 12,432,431(2) | $18.50 | $229,999,973.50 | $147.60 per $1,000,000 | $33,948 | ||||||||||||||||
| Fees Previously Paid |
— | — | — | — | — | — | — | — | ||||||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||
| Carry Forward Securities |
— | — | — | — | — | — | — | — | — | |||||||||||||||
| Total Offering Amounts | $33,948(1) | |||||||||||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||||||
| Net Fee Due | $33,948 | |||||||||||||||||||||||
| (1) | This “Calculation of Registration Fee” table shall be deemed to update the “Calculation of Registration Fee” table in the registrant’s Registration Statement on Form S-3ASR (File No. 333-254661), which was filed on March 24, 2021, in accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended. The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering. |
| (2) | Includes 1,621,621 shares of common stock issuable upon exercise of the underwriters’ option to purchase additional shares of common stock. |